Merck & Co. Inc.
PO Box 100
One Merck Drive
Whitehouse Station,
NJ 08889-0100
United States - Map
Phone: 908-423-1000
Fax: 908-735-1253
Web Site: http://www.merck.com
| Merck & Co., Inc. provides products for human and animal health primarily in the United States. The companys Pharmaceutical segment offers human health pharmaceutical products, such as therapeutic and preventive agents. Its products comprise Singulair, a leukotriene receptor antagonist for the treatment of asthma and allergic rhinitis; Cozaar, Hyzaar, Vasotec, and Vaseretic, the hypertension and/or heart failure products; Fosamax and Fosamax Plus D for treating osteoporosis; Januvia and Janumet for type 2 diabetes; Cosopt and Trusopt, the ophthalmological products; Zocor, an atherosclerosis product; Maxalt for acute migraine; Propecia to treat male pattern hair loss; Arcoxia to treat arthritis and pain; Proscar to treat symptomatic benign prostate enlargement; and Emend for the prevention of chemotherapy-induced and post-operative nausea and vomiting. Merck & Co.s Vaccines segment comprises human health vaccines, such as preventative pediatric, adolescent, and adult vaccines. Its products include Gardasil to prevent cervical cancer, pre-cancerous and low-grade lesions, vulvar and vaginal pre-cancers, and genital warts; Varivax to prevent chickenpox; ProQuad, a pediatric combination vaccine against measles, mumps, rubella, and varicella; M-M-R II, a vaccine against measles, mumps, and rubella; RotaTeq to protect against rotavirus gastroenteritis in children; Zostavax for preventing shingles; Primaxin and Cancidas, anti-bacterial/anti-fungal products; Isentress, Crixivan, and Stocrin, antiretroviral therapies for the treatment of HIV infection; and Invanz for the treatment of infection. Merck & Co. has research, collaboration, or licensing agreements with Neuromed Pharmaceuticals, Ltd.; ARIAD Pharmaceuticals, Inc.; GTX, Inc.; Idera Pharmaceuticals; Japan Tobacco Inc.; Galapagos NV; AstraZeneca plc; Metabasis Therapeutics Inc.; Addex Pharmaceuticals Ltd.; and Nuevolution A/S. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Richard T. Clark , 63
Exec. Chairman, Chief Exec. Officer and Pres |
$
4.03M |
$
0 | Mr. Peter N. Kellogg , 52
Chief Financial Officer and Exec. VP |
$
1.60M |
$
0 | Mr. Kenneth C. Frazier , 54
Exec. VP and Pres of Global Human Health |
$
2.00M |
$
0 | Dr. Peter Kim Ph.D., 50
Exec. VP and Pres of Merck Research Laboratories |
$
1.91M |
$
0 | Mr. Bruce N. Kuhlik , 52
Exec. Vice president and Gen. Counsel |
$
1.25M |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.14% Nasdaq 
1.13 (3.20%) 
Profile
